Healthcare & Life Sciences Private Equity Deal Tracker: Thomas H. Lee Partners and Frazier Healthcare Partners Acquire Adare Pharmaceuticals

McGuireWoods LLP

Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals from TPG Capital, according to a news release.

Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions, is a Lawrenceville, N.J.-based specialty contract development and manufacturing organization and global provider of pharmaceutical technologies, development and manufacturing. Adare has developed and manufactured more than 40 products sold in more than 100 countries.

Thomas H. Lee Partners, based in Boston, is private equity firm investing in middle-market growth companies. Founded in 1974, the firm invests in healthcare and a few other sectors and typically targets companies with enterprise values between $250 million and $2.5 billion.

Frazier Healthcare Partners, based in Seattle, is middle market private equity firm focused exclusively on healthcare. Founded in 1991, the firm’s growth buyout team seeks control equity investments in the provider services and hospitals/major facilities industries. Frazier prefers to make more substantial investments from a dollars perspective and pursues companies with revenues of at least $50 million.

TPG Capital, with its U.S. headquarters in Fort Worth, Texas, and San Francisco, is a global alternative asset firm founded in 1992 that invests in healthcare and a number of other industries.

Terms of the transaction were not disclosed.

Written by:

McGuireWoods LLP

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.